NCT07802496Not yet recruiting
Genetically Informed Screening for Early-Stage Type 1 Diabetes
Polygenic Assessment and Autoimmunity Testing for Health-System Screening of Type 1 Diabetes (PATHS-T1D)
Source: ClinicalTrials.gov · Last updated 8 Sept 2026
Brief summary (registry, in English)
This study is a test to find out if genetic information can be used to help healthcare providers identify diseases. Specifically, the investigators want to find out how genetic information can help healthcare providers identify people who may benefit from early screening for type 1 diabetes, even before people feel sick. This study aims to guide future research to improve screening, prevent disease, slow progression, and expand treatment options for type 1 diabetes.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 28 Aug 2026
- Start date
- 15 Oct 2026
- Primary completion date
- 1 Oct 2029
- Lead sponsor
- Massachusetts General Hospital
- Diseases
- Type 1 diabetes
- NCT number
- NCT07802496
What you commit to
- Study type: Observational
- Planned participants: 150
- From 15 Oct 2026 to the primary completion date, 1 Oct 2029
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Individuals with current or prior treatment with immune checkpoint inhibitors (e.g., PD-1, PD-L1, or CTLA-4 inhibitors), as well as individuals with diabetes secondary to pancreatic disease, including pancreatic cancer, pancreatitis, pancreatic surgery/pancreatectomy, cystic fibrosis, or hemochromatosis
Who the study is looking for
- Adults aged 18-79 years who had participated in the Mass General Brigham (MGB) Biobank and agreed to be recontacted for future study
Age in the registry: 18 years to 79 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.